CIK 0001357874
- Non-accelerated filer
- Smaller reporting company
PRECISION BIOSCIENCES INC
Sign in to watch- Ticker
- DTIL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- May 21
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 919-314-5512
- Business address
- 302 EAST PETTIGREW STREET, SUITE A-100, DURHAM, NC, 27701
- Open-market buys, last 90 days
- $29,501
- in 3 filings
- Open-market sales, last 90 days
- $27,505
- in 1 filing, $28K under 10b5-1 plans
Net +$1,996. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 39 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-11-02 | Amoroso Michael President and CEO | Grant or award · Restricted Stock Units | +850,000 | 850,000 | ||
| 2022-10-24 | Amoroso Michael President and CEO | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2022-10-17 | Amoroso Michael President and CEO | Sale | −11,006 | $1.32 | $15K | 13,202 |
| 2022-10-15 | Amoroso Michael President and CEO | Option exercise | +24,208 | 24,208 | ||
| 2022-10-15 | Amoroso Michael President and CEO | Option exercise · Restricted Stock Units | −24,208 | 0 | ||
| 2022-09-23 | Kelly John Alexander Chief Financial Officer | Purchase | +8,200 | $1.23 | $10K | 162,938 |
| 2022-09-22 | Kelly John Alexander Chief Financial Officer | Purchase | +37,037 | $1.34 | $50K | 154,738 |
| 2022-06-22 | Kelly John Alexander Chief Financial Officer | Purchase | +33,784 | $1.50 | $51K | 117,701 |
| 2022-06-08 | JANTZ DEREK Chief Scientific Officer | Sale | −18,849 | $2.06 | $39K | 4,055,174 |
| 2022-06-08 | Scimeca Dario General Counsel and Secretary | Sale | −9,833 | $2.06 | $20K | 32,514 |
| 2022-06-07 | JANTZ DEREK Chief Scientific Officer | Option exercise | +29,545 | 4,061,824 | ||
| 2022-06-07 | JANTZ DEREK Chief Scientific Officer | Option exercise | +12,199 | 4,074,023 | ||
| 2022-06-07 | JANTZ DEREK Chief Scientific Officer | Option exercise · Restricted Stock Units | −29,545 | 29,545 | ||
| 2022-06-07 | JANTZ DEREK Chief Scientific Officer | Option exercise · Restricted Stock Units | −12,199 | 24,391 | ||
| 2022-06-07 | Scimeca Dario General Counsel and Secretary | Option exercise | +22,727 | 33,300 | ||
| 2022-06-07 | Scimeca Dario General Counsel and Secretary | Option exercise | +9,047 | 42,347 | ||
| 2022-06-07 | Scimeca Dario General Counsel and Secretary | Option exercise · Restricted Stock Units | −22,727 | 22,727 | ||
| 2022-06-07 | Scimeca Dario General Counsel and Secretary | Option exercise · Restricted Stock Units | −9,047 | 18,089 | ||
| 2022-06-07 | Kelly John Alexander Chief Financial Officer | Option exercise | +34,090 | 70,279 | ||
| 2022-06-07 | Kelly John Alexander Chief Financial Officer | Option exercise | +13,638 | 83,917 |
Page 15 of 23 · 456 trades